Skip to content
BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP

Synergy CHC Corp. SNYRQ

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$30.4M
▼ 12.8% YoY
$-12.3M
▼ 680.8% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 30.4M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 30.4 · Net income -12.3
15M30M-5M-10M
20122015201820242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−41 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -27.8% · Net -40.6%
-5000%-10000%
201220172025
ROE
FY2018 · ROE -91.9%
-50%
201220172025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2018 · FCF 1.2
2.5M5.0M-0.4M-0.8M
201220172025
Net buybacks $M Dividends $M
FY2015 · Dividends 1.2 · Net buybacks ·
0.5M1.0M
2015

Total assetsUSD 10.2M
EquityUSD -23.1M
CashUSD 2.6M
Gross debtUSD 25.1M
Net debtUSD 22.4M
Current ratio1.22×

Equity was zero or negative — liabilities equaled or exceeded assets. No ratio is shown.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
SNYRQ, 11-year financial record
Metric 20252024202320192018201720162015201420132012
Revenue $B0.00.00.00.00.00.00.00.00.0◌◌
Operating income $B−0.00.00.0−0.0−0.00.00.00.0−0.0◌◌
EBITDA $B◌0.00.0−0.0−0.00.00.00.0−0.0◌◌
Income tax $B0.00.00.0−0.00.00.00.00.00.00.0◌
Net income $B−0.00.00.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B◌◌◌◌0.0−0.00.0−0.0◌◌◌
EPS, diluted $−1.270.280.86−0.10−0.070.01−0.01−0.11−0.010.000.00
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout %———————−16———
ROE %————−91.96.0−12.7————
Shares out B0.010.000.010.090.090.090.090.080.060.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 52 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 10 checks were skipped: the balance sheet is not tagged before 2012. Seven checks were skipped: revenue is not tagged before 2014. Five checks were skipped: EPS is not tagged before 2012.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inNevada
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2012

Share this section

Download image